Ogawa Yoshiyuki, Yanagisawa Kunio, Uchiyama Yuri, Matsumoto Akira, Inoue Madoka, Toyama Kohtaro, Miyazawa Yuri, Matsumoto Naomichi, Handa Hiroshi
Department of Hematology, Gunma University Hospital.
Department of Human Genetics, Yokohama City University Graduate School of Medicine.
Rinsho Ketsueki. 2018;59(4):383-388. doi: 10.11406/rinketsu.59.383.
Congenital combined deficiency of coagulation factor V (FV) and factor VIII (FVIII) (F5F8D) is a rare autosomal recessive bleeding disorder caused by mutations in lectin mannose-binding type 1 (LMAN1) or multiple coagulation factor deficiency 2 (MCFD2) encoding chaperone molecules involved in the intracellular transport of FV and FVIII. Here, we report a case of F5F8D in an elderly patient diagnosed with hematoma after a right thigh injury. A 71-year-old male had a history of abnormal bleeding after tooth extraction and cholecystectomy. The patient injured his right thigh with a kitchen knife; he was urgently hospitalized to a referral hospital 8 days later due to the occurrence of hematoma at the same site. Owing to prolongation of the coagulation time (PT 16.1 s, 1.72; APTT, 66.1 s), he received hemostatic treatment with fresh-frozen plasma. He was then referred to our hospital for examination of PT and APTT prolongation. FV and FVIII activities were moderately decreased to about 15%, and no inhibitor was detected. Whole-exome sequencing identified a previously reported homozygous nonsense mutation in LMAN1, revealing F5F8D in the proband. In this case, FFP infusion alone was not sufficient for increasing coagulation factor activities. Definitive diagnosis of F5F8D provides him with the treatment option with FVIII concentrates.
先天性凝血因子V(FV)和凝血因子VIII(FVIII)联合缺乏症(F5F8D)是一种罕见的常染色体隐性出血性疾病,由凝集素甘露糖结合蛋白1(LMAN1)或多重凝血因子缺乏症2(MCFD2)的突变引起,这两种基因编码参与FV和FVIII细胞内运输的伴侣分子。在此,我们报告一例老年患者的F5F8D病例,该患者右大腿受伤后被诊断为血肿。一名71岁男性有拔牙和胆囊切除术后异常出血史。患者被菜刀划伤右大腿;8天后,由于同一部位出现血肿,他被紧急送往一家转诊医院住院治疗。由于凝血时间延长(PT 16.1秒,1.72;APTT,66.1秒),他接受了新鲜冰冻血浆的止血治疗。随后他被转诊至我院检查PT和APTT延长的原因。FV和FVIII活性中度降低至约15%,未检测到抑制剂。全外显子组测序在LMAN1中鉴定出一个先前报道的纯合无义突变,揭示了先证者患有F5F8D。在这种情况下,仅输注新鲜冰冻血浆不足以提高凝血因子活性。F5F8D的明确诊断为他提供了使用FVIII浓缩物的治疗选择。